RSC Advances · 2022 · 32 citations · 35 references
Life SciencesBiochemistryMedicinal ChemistryDrug DiscoveryEnzymologyStructure-activity RelationshipsEnzyme InhibitionMedicinal PlantsAntidiabetic ActivityBioactive Plant CompoundsCarbohydrate-derived Enzyme InhibitorsEnzyme ActivityGlycosidase InhibitionProtein-ligand Complex ModelingRice BranTarget Enzyme Inhibition
screenings. The enzyme inhibition assay was corroborated by molecular docking and molecular dynamics simulation studies. Molecular docking studies suggested high binding energies and good binding interactions of these compounds with the active site residues of the receptor protein. A good agreement was found between the results of both modes of evaluation. The experimental results proved that the black rice bran extract can show 62% of alpha glucosidase inhibiting enzyme activity as compared to that of the popular drug Acarbose. While both the docking scores and binding affinity values indicate the formation of a ligand-enzyme complex by the major components of the extract, the molecular dynamics study further indicates the stability of the complex. The pharmacokinetic (ADMET properties) studies of these active compounds also support their use as safe oral anti-diabetic drugs. Thus, the results obtained from these studies of alpha glucosidase inhibition by bioactive compounds present in black rice bran indicate that these bioactive compounds can produce significant antidiabetic activity by inhibiting the active site of the target enzyme and hence these compounds can be used as leads for the synthesis of new antidiabetic drugs.
35
Development and testing of a general amber force field
Junmei Wang, Romain M. Wolf, James W. Caldwell et al. · Journal of Computational Chemistry · 2004 · 19.6K citations
Guidelines for accurate EC50/IC50 estimation
Jeanne L. Sebaugh · Pharmaceutical Statistics · 2010 · 939 citations
Pharmacy, Pharmacology, Toxicology +12